
Truxima (Rituximab-abbs Intravenous)
23 June, 2023
Valium injection
23 June, 2023Up and Up Nicotine
Category: U
Description
Generic name:
Nicotine
Drug class:
Nicotine replacement therapy (NRT); nicotinic cholinergic receptor agonist
Dosage form:
Transdermal patch (7 mg/24 h, 14 mg/24 h, 21 mg/24 h); Gum (2 mg, 4 mg); Lozenge (2 mg, 4 mg)
Route of administration:
Transdermal; Buccal (gum, lozenge)
Dose:
- Patches: 7–21 mg applied once daily (dose based on smoking level)
- Gum: 2 mg or 4 mg piece, 1 piece every 1–2 hours, up to 24 pieces/day
- Lozenge: 2 mg or 4 mg lozenge, 1 lozenge every 1–2 hours, up to 20 lozenges/day
Mechanism of action:
Nicotine acts as a nicotinic acetylcholine receptor agonist, stimulating dopaminergic pathways to alleviate withdrawal symptoms and reduce craving.
Drug usage cases:
- Smoking cessation therapy
- Reduction of nicotine withdrawal symptoms
Drug contraindications:
- Hypersensitivity to nicotine or any component of the formulation
- Recent myocardial infarction (within 2 weeks)
- Serious arrhythmias or unstable angina
Side effects:
- Local skin reactions (patch): erythema, pruritus, burning
- Oral irritation (gum/lozenge): mouth soreness, throat irritation, hiccups, dyspepsia
- Headache
- Dizziness
- Nausea and vomiting
- Insomnia, abnormal dreams
- Palpitations, tachycardia
- Increased blood pressure
- Dry mouth
- Impaired concentration
Warnings:
- Can be habit-forming; risks of continued nicotine exposure
- Not recommended for non-smokers
- Apply patches to clean, dry, hairless skin and rotate sites to reduce irritation
- Avoid use in patients with severe cardiovascular disease without physician supervision
- Accidental ingestion of nicotine in children can be fatal; keep out of reach
- Consult physician if signs of cardiovascular events occur
- May lower seizure threshold in predisposed patients
Use during pregnancy or breastfeeding:
Nicotine crosses the placental barrier and is present in breast milk. Animal studies suggest potential adverse effects on fetal development. NRT may be considered if non-pharmacologic cessation has failed and benefits outweigh risks. Use lowest effective dose for shortest duration. Discontinue breastfeeding or NRT if infant shows signs of nicotine exposure (irritability, tachycardia).